/5
0 avis
OA04-01. Safety and immunogenicity of LIPO-5, a HIV-1 lipopeptide vaccine: results of ANRS VAC18, a phase 2, randomized, double-blind, placebo-controlled trial
Archive ouverte
Edité par CCSD ; BioMed Central -
International audience. n.a
Consulter en ligne
Chargement des enrichissements...